RxDoctor Payments Data

Kelsey Hott, PA

Physician Assistant · Greensburg, KSNPI 1386896090

Payments from drug & device makers

$756in general payments, 2019–2025

Across 43 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$160
  • Lilly USA, LLC$147
  • Novo Nordisk$81
  • AstraZeneca$70
  • Edwards Lifesciences$49
  • Axsome Therapeutics, Inc.$44
  • plus $204 from 10 others

What the payments were for

  • Food & beverage$756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$756 in reported general payments places this provider in the 65th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$10,600
Medicare patients
31
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide172$187,527
Cosentyx (2 Syringes)Secukinumab14$106,393
JardianceEmpagliflozin66$49,024
XareltoRivaroxaban66$47,156
EliquisApixaban87$45,526
XifaxanRifaximin12$40,703
Tresiba Flextouch U-200Insulin Degludec58$40,258
FarxigaDapagliflozin Propanediol56$32,069
JanuviaSitagliptin Phosphate51$28,848
LinzessLinaclotide42$25,980
TrulicityDulaglutide25$25,103
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$23,341
MounjaroTirzepatide19$23,248
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate11$18,035
Tresiba Flextouch U-100Insulin Degludec27$17,334

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$81$187,527172 claims
NovartisCosentyx (2 Syringes)$20$106,39314 claims
AstraZenecaFarxiga, Breztri Aerosphere$70$48,38081 claims
Lilly USA, LLCTrulicity, Mounjaro$147$48,35144 claims
PfizerEliquis$25$45,52687 claims
AbbVieLinzess$160$25,98042 claims
Sumitomo Pharma America, Inc.Gemtesa$22$9,85720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in Greensburg

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →